Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

AZT: ArcticZymes Technologies launches AZtaqT DNA Polymerase

ArcticZymes Technologies
Tromsø, Norway, 10 August 2023 - ArcticZymes Technologies ASA (OSE: AZT)
launches AZtaqT DNA Polymerase

ArcticZymes Technologies (AZT) today announces the launch of its new product,
AZtaqT DNA Polymerase. AZtaqT is a high-quality thermostable DNA polymerase
suitable for use in polymerase chain reaction (PCR) applications.

Launching the AZtaqT is a natural expansion of the Company's molecular tools
portfolio. Being an essential enzyme in PCR, the thermostable DNA polymerase
plays a pivotal role and enables numerous applications within molecular
diagnostics and research.

The Company expects to see synergies with their existing products currently
supporting PCR workflows. Being able to serve customers with a more complete
enzyme offering will be an important driver for sales growth in the molecular
tools business.

CSO, Darren Ellis said: "Taken by itself Taq polymerase is a relatively standard
product
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.